Advertisement
Screener

OPTIMER PHARMACEUTICALS INC Forms 3, 4 and 5: Warrants

OPTIMER PHARMACEUTICALS INC Forms 3, 4 and 5: Warrants

Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 18 rows, 4 shown. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.

  • 2009-03-04: Reporting owner SCHREIBER ALAIN; Form 4; Security Warrants to purchase common stock; Transaction P Open market or private purchase of non-derivative or derivative security.
  • 2009-03-04: Reporting owner SCHREIBER ALAIN; Form 4; Security Warrants to purchase common stock; Transaction P Open market or private purchase of non-derivative or derivative security.
  • 2009-03-04: Reporting owner SCHREIBER ALAIN; Form 4; Security Warrants to purchase common stock; Transaction P Open market or private purchase of non-derivative or derivative security.
  • 2009-03-04: Reporting owner SCHREIBER ALAIN; Form 4; Security Warrants to purchase common stock; Transaction P Open market or private purchase of non-derivative or derivative security.
Transaction dateReporting ownerFormSecurityTransactionSharesPricePrice that dayFiling
2009-03-04SCHREIBER ALAIN
Director
4Warrants to purchase common stock
Derivative · Indirect · by ProQeust Investment II, L.P.
P Open market or private purchase of non-derivative or derivative security+35,123
35,123 owned after
$10.93
exercise price
2009-03-06
2009-03-04SCHREIBER ALAIN
Director
4Warrants to purchase common stock
Derivative · Indirect · by ProQuest Investments II Advisors Funds, L.P.
P Open market or private purchase of non-derivative or derivative security+1,490
1,490 owned after
$10.93
exercise price
2009-03-06
2009-03-04SCHREIBER ALAIN
Director
4Warrants to purchase common stock
Derivative · Indirect · by ProQuest Investments III, L.P.
P Open market or private purchase of non-derivative or derivative security+18,307
18,307 owned after
$10.93
exercise price
2009-03-06
2009-03-04SCHREIBER ALAIN
Director
4Warrants to purchase common stock
Derivative · Indirect · ProQeust Investments, IV, L.P.
P Open market or private purchase of non-derivative or derivative security+36,613
36,613 owned after
$10.93
exercise price
2009-03-06